CoChat

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC) are breast cancer subtypes with an especially poor prognosis. 8-Hydroxydeoxyguanosine (8-OHdG) is a widely used marker of oxidative stress and the redox-state-regulating enzymes peroxiredoxins (PRDXs) are efficient at depressing excessive reactive oxygen species. NF-E2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) are redox-sensitive transcription factors that regulate PRDX expression. This is the first study to assess oxidative stress and or cell redox state-regulating enzymes in TNBC and BLBC. METHODS: We assessed immunohistochemical expression of 8-OHdG, Nrf2, Keap1, PRDX III and PRDX IV in 79 women with invasive ductal breast carcinomas. Of these tumors, 37 represented TNBC (grade II-III tumors with total lack of ER, PR and human epidermal growth factor receptor 2 [HER2] expression). Control cases (n = 42) were ER-positive, PR-positive and HER2-negative. Of the 37 TNBCs, 31 had BLBC phenotype (TNBC with expression of cytokeratin 5/6 or epidermal growth factor receptor 1). RESULTS: Patients with TNBC had worse breast cancer-specific survival (BCSS) than the control group (p = 0.015). Expression of 8-OHdG was significantly lower in TNBC than in the non-TNBC group (p < 0.005). 8-OHdG immunostaining was associated with better BCSS (p = 0.01), small tumor size (p < 0.0001) and low grade (p < 0.0005). Keap1 overexpression was observed in the TNBC cohort (p = 0.001) and Keap1-positive patients had worse BCSS than Keap1-negative women (p = 0.014). PRDX IV was overexpressed in the TNBC vs. the non-TNBC group (p = 0.022). CONCLUSIONS: Cellular redox state markers may be promising targets when elucidating the pathogenesis of TNBC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-11-262

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Kaplan-Meier curves showing breast cancer-specific survival in different subgroups. TNBC patients have significantly shorter survival compared the control group (p = 0.015) (A). Women with 8-OHdG-positive tumors have better breast cancer-specific survival when all patients are taken into account (p = 0.011) (B).
Figure 1 Kaplan-Meier curves showing breast cancer-specific survival in different subgroups. TNBC patients have significantly shorter survival compared the control group (p = 0.015) (A). Women with 8-OHdG-positive tumors have better breast cancer-specific survival when all patients are taken into account (p = 0.011) (B).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 87

Metadata

Authors
Karihtala, P., Kauppila, S., Soini, Y., & Arja-Jukkola-Vuorinen
Affiliations
  • Oulu University Hospital (FI)
  • University of Eastern Finland (FI)
Corresponding author
Karihtala, Peeter
Venue
BMC Cancer
Published
2011-06-21
Volume
11
Issue
1
Pages
262-262
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2066549335
Cited by
87
References
29
Citations by year
2026: 5 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 11 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 4 · 2012: 3
FWCI
2.21
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Suomen Lääketieteen Säätiö
  • Filha
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
triple-negative breast cancer, basal-like breast cancer, oxidative stress, 8-hydroxy-2'-deoxyguanosine, Nrf2, Keap1, peroxiredoxin III, redox state, breast cancer-specific survival, hormone receptor-positive breast cancer, invasive ductal carcinoma, prognostic factors
MeSH terms
Kelch-Like ECH-Associated Protein 1, 8-Hydroxy-2'-Deoxyguanosine, Breast Neoplasms, Basal Cell Carcinoma, Deoxyguanosine, Female, Follow-Up Studies, Humans, Immunohistochemistry, Oxidation-Reduction, Prognosis, Receptors, Estrogen, Receptors, Progesterone, Cohort Studies, Carcinoma, Ductal, Breast, Oxidative Stress, Erb-b2 Receptor Tyrosine Kinases, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Kaplan-Meier Estimate, Peroxiredoxins, Peroxiredoxin III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. https://app.cochat.ai/papers/10.1186/1471-2407-11-262
The paper
Karihtala, P., Kauppila, S., Soini, Y., & Arja-Jukkola-Vuorinen. (2011). Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer. https://doi.org/10.1186/1471-2407-11-262

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.